Christiana Stamoulis - 14 Jul 2025 Form 4 Insider Report for INCYTE CORP (INCY)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
16 Jul 2025, 16:03:58 UTC
Prior SEC filing
07 Jul 2025
Next SEC filing
25 Sep 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Elizabeth Feeney, Attorney-In-Fact

Key filing fact

Christiana Stamoulis filed Form 4 for INCYTE CORP (INCY) on 16 Jul 2025.

Key facts

  • This page summarizes Christiana Stamoulis's Form 4 filing for INCYTE CORP (INCY).
  • 5 reported transactions and 2 derivative rows are listed below.
  • Accepted by SEC: 16 Jul 2025, 16:03.

Change

  • Previous filing in this sequence was filed on 07 Jul 2025.
  • Current net transaction value: -$197,083.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001502917 Primary reporting owner

Stamoulis Christiana

Relationship
EVP & Chief Financial Officer
Address
1801 AUGUSTINE CUT-OFF, WILMINGTON
Signature
/s/ Elizabeth Feeney, Attorney-In-Fact
Signature date
16 Jul 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

INCY transaction

Common Stock

Tax liability

Transaction value
$98,462
Shares
-1,407
Change %
-1.2%
Price
$69.98
Shares after
116,097
Date
14 Jul 2025
Ownership
Direct
Footnotes
F1
INCY transaction

Common Stock

Tax liability

Transaction value
$98,621
Shares
-1,445
Change %
-1.2%
Price
$68.25
Shares after
114,652
Date
15 Jul 2025
Ownership
Direct
Footnotes
F1
INCY transaction

Common Stock

Award

Transaction value
$0
Shares
+11,107
Change %
+9.7%
Price
$0.000000
Shares after
125,759
Date
15 Jul 2025
Ownership
Direct
Footnotes
F2, F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

INCY transaction Derivative

Performance Shares

Award

Transaction value
$0
Shares
+27,769
Change %
Price
$0.000000
Shares after
27,769
Date
15 Jul 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
27,769
Exercise price
Footnotes
F4
INCY transaction Derivative

Employee Stock Option (right to buy)

Award

Transaction value
$0
Shares
+24,998
Change %
Price
$0.000000
Shares after
24,998
Date
15 Jul 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
24,998
Exercise price
$68.25
Footnotes
F5
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 5 footnotes

Footnote F1

Represents shares withheld automatically by the Issuer to satisfy tax withholding obligations due at settlement of RSUs or earned performance shares previously reported in Table I as common stock.

Footnote F2

Represents award of restricted stock units ("RSUs") that will vest 25% annually over four years. The RSUs may be settled only for shares of common stock on a one-for-one basis.

Footnote F3

Including the July 15, 2025 grant, this includes an aggregate of 64,006 shares of common stock issuable pursuant to previously reported RSUs and earned performance shares that have not vested.

Footnote F4

Each performance share represents the right to receive up to 200% of one share of common stock. Such shares may be earned based upon the issuer's relative total shareholder return ("TSR") over a three-year performance period beginning on January 1, 2025 as compared to the TSR of companies in a fixed peer group, as set forth in the Performance Share Award Agreement. The earned shares will vest on the third anniversary of the grant date subject to the Reporting Person's continued service with the issuer.

Footnote F5

The July 15, 2025 options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .